Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Abdullah S. Al-Zahrani"'
Autor:
Amrallah A. Mohammed, Hani EL-Tanni, Hafez M. Ghanem, Mian U. Farooq, Amr M. El Saify, Abdullah S. Al-Zahrani, Ayman EL-Shentenawy, Hani M. EL-Khatib
Publikováno v:
Journal of the Egyptian National Cancer Institute, Vol 27, Iss 3, Pp 155-159 (2015)
Background: This study evaluates the correlation between body mass index (BMI) and clinicopathological parameters of metastatic prostate cancer (MPC) and its impact on survival. Method: During the study period, 71 MPC patients were eligible. Patients
Externí odkaz:
https://doaj.org/article/d46a28a70977407b9da6b12ff0a3a304
Autor:
Amrallah A. Mohammed, Abdullah S. Al-Zahrani, Hafez M. Ghanem, Mian U. Farooq, Amr M. El Saify, Hani M. EL-Khatib
Publikováno v:
Journal of the Egyptian National Cancer Institute, Vol 27, Iss 1, Pp 35-39 (2015)
Background: This study evaluates the use of palliative chemotherapy (PCT) and possible associated factors at the end of life. Method: The study includes all advanced non hematological cancer patients who died in the King Abdullah Medical City during
Externí odkaz:
https://doaj.org/article/ed1957b2bfd0462caebb1e276fe67e1c
Autor:
Amrallah A. Mohammed, Abdullah S. Al-Zahrani, Mohamed A. Sherisher, Ahmad A. Alnagar, Ayman EL-Shentenawy, Amr T. El-Kashif
Publikováno v:
Journal of the Egyptian National Cancer Institute, Vol 26, Iss 3, Pp 147-152 (2014)
Background: Although cancer patients are susceptible to infection, there is no evidence-based published guideline on the appropriate use of antimicrobial treatment in this group of patients. Methods: We retrospectively collected medical records of al
Externí odkaz:
https://doaj.org/article/8d6208f85961458387cd0f540b5ecb44
Publikováno v:
Forum of Clinical Oncology, Vol 7, Iss 2, Pp 1-6 (2016)
Purpose Adjuvant trastuzumab is currently an internationally standard for the treatment of localised breast cancer that over express HER2 with the most adverse effect being cardiotoxicity. We conducted this study to evaluate the cardiac safety of tra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ac343589bffe395eb4ee16b46cba7cc
https://doi.org/10.1515/fco-2016-0007
https://doi.org/10.1515/fco-2016-0007
Autor:
Abdullah S. Al-Zahrani, Ahmad A. Raheem, Mohamed A. Sherisher, Hafez M. Ghanem, Amrallah A. Mohammed, Amr T. El-Kashif, Samy A. Alsirafy
Publikováno v:
American Journal of Hospice and Palliative Medicine®. 33:658-662
Frequent emergency department visits (EDVs) by patients with terminal cancer indicates aggressive care. The pattern and causes of EDVs in 154 patients with terminal cancer were investigated. The EDVs that started during working hours and ended by hom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1348874b0ada93818ea046b16ff7750d
https://doi.org/10.1177/1049909115581819
https://doi.org/10.1177/1049909115581819
Autor:
Hafez M. Ghanem, Amrallah A. Mohammed, Hani M. EL-Khatib, Mian U. Farooq, Abdullah S. Al-Zahrani, Amr M. El Saify
Publikováno v:
Journal of the Egyptian National Cancer Institute, Vol 27, Iss 1, Pp 35-39 (2015)
Background This study evaluates the use of palliative chemotherapy (PCT) and possible associated factors at the end of life. Method The study includes all advanced non hematological cancer patients who died in the King Abdullah Medical City during th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa2f8e64a545f18f081896e52979970d
https://doi.org/10.1016/j.jnci.2015.02.001
https://doi.org/10.1016/j.jnci.2015.02.001
Publikováno v:
Forum of Clinical Oncology, Vol 5, Iss 1, Pp 6-10 (2014)
In our centre, among 1965 registered cancer patients between May 2011 and December 2013, we report three cases with multiple primary malignant neoplasms. One of them was excluded due to lack of data, and so we present the remaining two cases. The fir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcc85291ba4d2cb31b09a6c7442bb158
https://doi.org/10.2478/fco-2014-0002
https://doi.org/10.2478/fco-2014-0002
Autor:
Shereef Elsamany, Samy A. Alsirafy, Abdullah S. Al-Zahrani, Amr T. El-Kashif, Amrallah A. Mohammad
Publikováno v:
American Journal of Hospice and Palliative Medicine®. 30:707-711
The prediction of in-hospital mortality may help in improving end-of-life care for patients dying of cancer. The Chuang Prognostic Score (CPS) was developed to predict survival of terminally ill patients with cancer. The CPS was assessed in 61 hospit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::947f025dd432c478fe339062f6f21b88
https://doi.org/10.1177/1049909112467362
https://doi.org/10.1177/1049909112467362
Autor:
Abdullah S. Al-Zahrani, Amrallah A. Mohammed, Sheriff M El-Seman, Ahmed Osman, Osama A Abbas, Gamal M. Elnemr, Ahmed H El-Rashidy, Abdelghani A Hassan, Lotfi F Issa
Publikováno v:
Asian Pacific journal of cancer prevention : APJCP. 17(2)
Triple-negative breast cancers constitute about 15% of all cases, but despite their higher response to neoadjuvant chemotherapy, the tumors are very aggressive and associated with a poor prognosis as well as a higher risk of early recurrence. This st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46f2e4269dca42c7d2b3ec2fca38922b
https://pubmed.ncbi.nlm.nih.gov/26925684
https://pubmed.ncbi.nlm.nih.gov/26925684
Autor:
Mohammed M. Abbas, Mohamed A. Sherisher, Ayman Rasmy, Miral Mashhour, Soha Elmorsy, Amrallah A. Mohammed, Waleed Abozeed, Shereef Elsamany, Abdullah S. Al-Zahrani
Publikováno v:
Asian Pacific journal of cancer prevention : APJCP. 16(17)
Purpose: This study aimed to explore the value of IHC4 in predicting pathological response after neoadjuvant chemotherapy in patients with hormonal receptor (HR)-positive breast cancer (BC). Materials and Methods: In this retrospective exploratory st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ef2c369cecaeb1517f9e98a60576e01
https://pubmed.ncbi.nlm.nih.gov/26625828
https://pubmed.ncbi.nlm.nih.gov/26625828